REVERSED
1600 Biotechnology and Organic Chemistry
1616 Ex Parte Code 12/012,297 WALSH 103(a) Mark A. Litman & Associates, P.A. CHOI, FRANK I
“The Patent Office has the initial duty of supplying the factual basis for its rejection. It may not . . . resort to speculation, unfounded assumptions or hindsight reconstruction to supply deficiencies” in the cited references. In re Warner, 379 F.2d 1011, 1017 (CCPA 1967).
Warner, In re, 379 F.2d 1011, 154 USPQ 173 (CCPA 1967) . . . . . . . . . . . . . . . . . . . . . . .2142
3700 Mechanical Engineering, Manufacturing, and Products & Design
3761 Ex Parte Nordness et al 10/316,964 GRIMES 102(e)/103(a) DORITY & MANNING, P.A. KIDWELL, MICHELE M
AFFIRMED-IN-PART
2800 Semiconductors, Electrical and Optical Systems and Components
2833 Ex Parte Bena et al 11/714,935 HOMERE 103(a) 102(b)/103(a) CANTOR COLBURN LLP IMAS, VLADIMIR
AFFIRMED
1700 Chemical & Materials Engineering
1716 Ex Parte Yoo et al 11/466,922 GAUDETTE 103(a) DUANE MORRIS LLP (TSMC) DHINGRA, RAKESH KUMAR
2400 Networking, Mulitplexing, Cable, and Security
2424 Ex Parte Wachtfogel et al 11/599,216 NAPPI 112(1)/102(b) Husch Blackwell LLP SHELEHEDA, JAMES R
Tech Center 2800 Semiconductors, Electrical and Optical Systems and Components
2816 Ex Parte Baumgartner et al 11/866,110 ZECHER 101/102(b) IBM CORPORATION ENGLUND, TERRY LEE
The Court of Customs and Patent Appeals, predecessor court to the Court of Appeals for the Federal Circuit, held that “[e]ach case is determined on its own merits. In reviewing specific rejections of specific claims, this court does not consider allowed claims in other applications or patents.” In re Gyurik, 596 F.2d 1012, 1018 n. 15 (CCPA 1979) (citations omitted).
